Fountzilas, E.; Aravantinou-Fatorou, E.; Dadouli, K.; Economopoulou, P.; Tryfonopoulos, D.; Vernadou, A.; Vorrias, E.; Vagionas, A.; Nikolaidi, A.; Karageorgopoulou, S.;
et al. Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study. Cancers 2025, 17, 2543.
https://doi.org/10.3390/cancers17152543
AMA Style
Fountzilas E, Aravantinou-Fatorou E, Dadouli K, Economopoulou P, Tryfonopoulos D, Vernadou A, Vorrias E, Vagionas A, Nikolaidi A, Karageorgopoulou S,
et al. Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study. Cancers. 2025; 17(15):2543.
https://doi.org/10.3390/cancers17152543
Chicago/Turabian Style
Fountzilas, Elena, Eleni Aravantinou-Fatorou, Katerina Dadouli, Panagiota Economopoulou, Dimitrios Tryfonopoulos, Anastasia Vernadou, Eleftherios Vorrias, Anastasios Vagionas, Adamantia Nikolaidi, Sofia Karageorgopoulou,
and et al. 2025. "Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study" Cancers 17, no. 15: 2543.
https://doi.org/10.3390/cancers17152543
APA Style
Fountzilas, E., Aravantinou-Fatorou, E., Dadouli, K., Economopoulou, P., Tryfonopoulos, D., Vernadou, A., Vorrias, E., Vagionas, A., Nikolaidi, A., Karageorgopoulou, S., Koumarianou, A., Boukovinas, I., Mauri, D., Kokkali, S., Christopoulou, A., Tsoukalas, N., Assi, A., Spathas, N., Kosmidis, P.,
... Psyrri, A.
(2025). Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study. Cancers, 17(15), 2543.
https://doi.org/10.3390/cancers17152543
